Disclosures for "Admission Coagulopathies on Viscoelastic Hemostatic Assays Predict Infection after Intracerebral Hemorrhage"
-
Ms. Sieh has nothing to disclose.
-
Miss Peasley has nothing to disclose.
-
Dr. Ghoshal has nothing to disclose.
-
Dr. Agarwal has nothing to disclose.
-
Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health.
-
Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
-
Dr. Roh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Portola Pharmaceuticals.